Paper Details 
Original Abstract of the Article :
In a prospective, open study 45 patients (mean age fifty-three years) with essential hypertension were treated with verapamil for four to eight years (mean 5.3 years). Blood pressure was satisfactorily controlled (from 160/104 to 145/91) and the side effects were infrequent, mild, and often transien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/000331978803901204

データ提供:米国国立医学図書館(NLM)

Verapamil: A Safe Oasis in the Desert of Hypertension

Imagine a vast desert, where the sun beats down relentlessly and the traveler must navigate treacherous terrain. Hypertension, a common condition that can put a strain on the cardiovascular system, is like a hidden sandstorm lurking in the desert. This study investigates the long-term metabolic effects of verapamil, a calcium channel blocker commonly used to treat hypertension, offering a potential safe haven in the desert of hypertension.

The study found that long-term treatment with verapamil did not result in any adverse metabolic effects, even after several years of use. This is like finding a hidden oasis with a refreshing spring that not only provides relief from thirst but also promotes well-being. Verapamil was found to be a safe and effective treatment for hypertension, without negatively impacting metabolic health.

A Safe Haven in the Desert: Verapamil and Hypertension

This study suggests that verapamil is a metabolically safe drug for long-term treatment of essential hypertension. This is like finding a safe and reliable oasis in the desert, providing a haven for those battling this condition.

Living in the Desert of Hypertension: Implications for Patients

This research offers valuable information for individuals with hypertension. It suggests that verapamil may be a safe and effective treatment option for long-term management of this condition. Patients should discuss the potential benefits and risks of verapamil with their doctors to make informed decisions about their care.

Dr.Camel's Conclusion

This study highlights the metabolic safety of verapamil in the long-term treatment of essential hypertension. This finding offers a glimmer of hope for individuals seeking a safe and effective treatment option for managing this challenging condition. It's a testament to the importance of understanding the potential long-term effects of medications and finding solutions that promote both health and well-being.

Date :
  1. Date Completed 1988-12-22
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

3189948

DOI: Digital Object Identifier

10.1177/000331978803901204

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.